Trials / Completed
CompletedNCT03085667
Impact of Implantation of an LAA Occluder on ANP and BNP Level and Quality of Life
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- University of Leipzig · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Closure of the LAA by several devices is a alternative therapy to oral anticoagulation in patients with Atrail fibrillation. Nothing is known about the acute influence of a device closure of the LAA on the secretion of ANB nad BNP hormones. Therefore aim of our study is to measure ANB and BNP levvels before and after Implantation of an LAA closure device.
Detailed description
ANB and BNP levels are measured before, directly after and late after 24 h in central or periphereal venous blood from patients undergoing interventional LAA closure.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2015-01-01
- Completion
- 2015-12-01
- First posted
- 2017-03-21
- Last updated
- 2020-03-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03085667. Inclusion in this directory is not an endorsement.